Literature DB >> 921378

The clinical and physiological effect of whole-lung lavage in pulmonary alveolar proteinosis: a ten-year experience.

P A Selecky, K Wasserman, J R Benfield, M Lippmann.   

Abstract

We have utilized whole-lung lavage in the successful treatment of 18 patients with pulmonary alveolar proteinosis. Our ten-year experience includes serial evaluations of patients with disabling lung dysfunction who had a total of 49 whole-lung lavages under general anesthesia. Clinical and physiological responses were documented both before and after each lavage. There were no complications or deaths. All patients were radiographically, physiologically, and symptomatically improved within hours after the procedures. Five patients required from two to four repeat lavages one to three years later. The treatment of this disorder has included a wide variety of techniques. We attribute our results to the use of a lung lavage technique that includes: (1) unilateral whole-lung lavages at two to three day intervals; (2) isotonic saline as the lavage solution; (3) use of a mechanical chest percussor during lavage; and (4) measuring the total thoracic compliance of each side in the immediate postlavage period as a guide for extubation. We conclude that whole-lung lavage is a safe, highly effective, repetitively applicable treatment for pulmonary alveolar proteinosis.

Entities:  

Mesh:

Year:  1977        PMID: 921378     DOI: 10.1016/s0003-4975(10)63440-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years.

Authors:  K Kariman; J A Kylstra; A Spock
Journal:  Lung       Date:  1984       Impact factor: 2.584

3.  Lipoprotein macroaggregates in bronchoalveolar lavage fluid from patients with diffuse interstitial lung disease: comparison with idiopathic alveolar lipoproteinosis.

Authors:  P L Haslam; D A Hughes; A Dewar; C F Pantin
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

4.  Alveolar proteinosis lung lavage using partial cardiopulmonary bypass.

Authors:  A P Freedman; A Pelias; R F Johnston; I P Goel; H I Hakki; T Oslick; J P Shinnick
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

5.  Therapeutic lung lavages in children and adults.

Authors:  Christian Paschen; Karl Reiter; Franz Stanzel; Helmut Teschler; Matthias Griese
Journal:  Respir Res       Date:  2005-11-22

6.  The effectiveness of N-acetylcysteine for an adult case of pulmonary alveolar proteinosis: A case report.

Authors:  Haiyan Zhang
Journal:  Respir Med Case Rep       Date:  2019-06-14

7.  Anaesthetic considerations for whole lung lavage for pulmonary alveolar proteinosis.

Authors:  Anuja Pandit; Nishkarsh Gupta; Karan Madan; Sachidanand J Bharti; Vinod Kumar
Journal:  Ghana Med J       Date:  2019-09

8.  Rituximab for auto-immune alveolar proteinosis, a real life cohort study.

Authors:  Berenice Soyez; Raphael Borie; Cedric Menard; Jacques Cadranel; Leonidas Chavez; Vincent Cottin; Emmanuel Gomez; Sylvain Marchand-Adam; Sylvie Leroy; Jean-Marc Naccache; Hilario Nunes; Martine Reynaud-Gaubert; Laurent Savale; Abdellatif Tazi; Lidwine Wemeau-Stervinou; Marie-Pierre Debray; Bruno Crestani
Journal:  Respir Res       Date:  2018-04-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.